Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009
Aug 20, 2018 --Company Announces Preliminary Fiscal 2018 Fourth-Quarter and Full-Year Financial Results; To Host Conference Call Today at 8 a.m. ET-- Lannett Company, Inc. (NYSE: LCI) today said that its distribution agreement with Jerome Stevens Pharmaceuticals (JSP), which expires on March 23, 2019, will not be renewed. "The Steinlauf family... More |
Aug 3, 2018 Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive perpetual licensing agreement with Andor Pharmaceuticals, LLC for Methylphenidate Hydrochloride Extended... More |
Jul 23, 2018 Lannett Company, Inc. (NYSE: LCI) today announced that it launched four products in June 2018, bringing to seven the total number of products launched since January 1, 2018. The June product... More |
Jun 29, 2018 Lannett Company, Inc. (NYSE: LCI) today announced a restructuring and cost reduction plan of its subsidiary, Cody Laboratories (Cody), a developer and manufacturer of pain management active... More |
Jun 1, 2018 Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Levofloxacin Oral... More |
May 21, 2018 Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Dronabinol Capsules... More |
May 7, 2018 --Adjusted EPS Higher Than Expected; Outlook for Fiscal 2018 Net Sales and Adjusted Profitability Affirmed-- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2018 third quarter ended March 31, 2018. "We continue to make good progress executing on our strategic... More |
May 7, 2018 --Transaction Includes 23 Approved and 1 Pending Drug Product Applications, Primarily Oral Solutions-- Lannett Company, Inc. (NYSE: LCI) today announced that it has acquired 23 approved and one pending drug product applications from a subsidiary of Endo International plc for an upfront payment plus... More |
May 3, 2018 Lannett Company, Inc. (NYSE: LCI) today announced its participation at two upcoming investor conferences. Schedule below: Deutsche Bank 43rd Annual Health Care Conference at 9:20 a.m. ET, on... More |
May 2, 2018 Lannett To Report Fiscal 2018 Third-Quarter Financial Results, Host Conference Call On Monday, May 7 Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2018 third quarter on Monday, May 7, 2018, after the market closes. Lannett management will... More |